A scalable mRNA synthesis platform for manufacturing mRNAs with batch consistency and high translational output
A scalable mRNA synthesis platform for manufacturing mRNAs with batch consistency and high translational output.
Applications: Synthesis of next generation mRNA therapeutics: vaccine development, cancer therapeutics, rare genetic disorder therapeutics, personalised medicine
| Features | Benefits |
|---|---|
| mRNA template plasmid platform with a novel template encoded poly(A) design | Improved plasmid stability in bacterial host during propagation and subcloning |
| Flexible poly(A) tail length design | Streamlines quality control process |
| Proprietary 5’ and 3’ UTR sequences in combination with signal peptide sequences | Streamlines regulatory compliance |
| Highly modular plasmid design | Production of synthesis mRNAs with poly(A) tails up to ~200 nucleotides in length |
| Maximising translational output | |
| Streamlines regulatory compliance | |
| High translational output of intracellular or secreted proteins | |
| Enables streamlined, speedy, and cost-effective manufacturing of novel/personalised mRNAs drugs |
Awaiting patent and Available For
- Co-development
- Consulting
- Licensing